InterMune Inc. (ITMN)

ITMN (NASDAQ:Drugs)
$9.58
neg -0.38
-3.82%
Today's Range: 9.53 - 9.87 | ITMN Avg Daily Volume: 1,295,300
Last Update: 05/24/13 - 4:00 PM EDT
Volume: 826,352
YTD Performance: -0.93%
Open: $9.87
Previous Close: $9.96
52 Week Range: $7.21 - $12.77
Oustanding Shares: 81,684,233
Market Cap: 783,543,974
6-Month Chart
TheStreet Ratings Grade for ITMN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 11 11 11
Moderate Buy 0 0 0 0
Hold 1 1 2 2
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 1.38 1.38 1.50 1.50
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -3.49
Price Earnings Comparisons:
ITMN Sector Avg. S&P 500
-3.49 0.00 17.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
8.35% -2.73% 7.50%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.10 -0.46 -0.19
Net Income 0.00 0.59 0.00
EPS 0.00 -0.12 0.00
Earnings for ITMN:
EBITDA -0.19B
Revenue 0.03B
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $-0.69 $-0.70 $-2.75 $-1.94
Number of Analysts 10 10 11 11
High Estimate $-0.60 $-0.62 $-2.52 $-1.70
Low Estimate $-0.76 $-0.74 $-2.95 $-2.34
Prior Year $-0.78 $-0.70 $-2.82 $-2.75
Growth Rate (Year over Year) 11.41% 0.00% 2.51% 29.50%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
US_proptrader: $ANV $ITMN $VVUS $ACAD $DANG $AG $AGQ $SWC charts at http://t.co/wjpxyxYK4Z 1157
4 days ago from Seesmic twhirl
ari5000: $ITMN - http://t.co/33x1jOCOFj [ http://t.co/cDmGWgbD4k ] #stockcharts added at 10 -- still in b/o mode.
5 days ago from Tweet Button
MikeOinSATX: #IRQ Friends: I forwarded research on $ITMN. Not an #IRQ Friend? IR questions & research are now archived at http://t.co/tqGZ7JSXOv #Biotech
5 days ago from web
MikeOinSATX: #Biotech #IRQ research on $ITMN: -a- BACKGROUND INFO: The Company's lead product/candidate is Esbriet® (cont) http://t.co/A9Il40xE2Y
5 days ago from Twitlonger
ChartMill: http://t.co/3RIxi0wNkX #stocks aftermarket moves on $$ $CPA $ITMN
5 days ago from www.chartmill.com
ChartMill: #stocks what moves aftermarket http://t.co/3RIxi0wNkX $$ $CPA $ITMN
7 days ago from www.chartmill.com
ChartMill: some aftermarket movers http://t.co/3RIxi0wNkX #stocks $$ $GST $ITMN
1 week ago from www.chartmill.com
Momentum21Fund: sold all my $ITMN at 10.05 and some $COOL at .6705
1 week ago from web
Bullish
Jan 16, 2013 | 8:38 AM EST
ITMN was upgraded to Buy from Neutral, UBS said. $15 price target. Short term hurdles removed. 
Bearish
Aug 15, 2012 | 8:13 AM EDT
Shares of ITMN now seen reaching $8.50, UBS said. Estimates also lowered to reflect Esbriet pricing and sales. Neutral rating.

Columnist Conversation / Market Updates

| May 24, 2013
| 3:24 PM EDT
There is no technical damage on the daily chart of $SPX at this point. Actually this decline is only similar to prior d...
| May 24, 2013
| 3:17 PM EDT
Metlife Inc. became very overbought last week reaching a level not seen in over a year. MET had been in rally mode...

Our Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.